BioPharma’s 300 bed capacity is split between our two research sites in Toronto, Canada and Columbia, USA. The teams at both centres are unified with a common goal to be a global leader in early stage research offering innovative, flexible and client-focused solutions to bring novel and affordable medicines to patients in need.

Led by a team of Medical Physicians, Scientists and Clinicians, clinical conduct and execution at BioPharma’s clinic facilities are expertly tailored to meet the multi-faceted needs and requirements of the drug product, protocol design and study objective while ensuring the safety and well-being of our subject volunteers.

To ensure the successful application and reproducibility of an assay, one must first define the quality with which the assay was first developed. The challenges of LC/MS/MS detection are compounded by the requirement for quantitation of low analyte concentrations, selectivity from endogenous compounds present in matrix while anticipating the metabolites that will be present in incurred samples. These complexities can all be managed with a rugged, robust and well developed assay that aligns with the regulatory requirements across multiple market jurisdictions. R&D is the foothold of our lab that allows for the successful execution of the most complex of studies with timely and accurate results.